HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter A Andreasen Selected Research
Peter A Andreasen Research Topics
Disease
25
Neoplasms (Cancer)
01/2019 - 06/2002
7
Neoplasm Metastasis (Metastasis)
01/2019 - 03/2004
4
Carcinoma (Carcinomatosis)
09/2011 - 05/2003
3
Breast Neoplasms (Breast Cancer)
01/2019 - 05/2003
3
Autolysis
01/2013 - 02/2009
2
Sepsis (Septicemia)
10/2020 - 01/2008
2
Thrombosis (Thrombus)
10/2020 - 03/2016
2
Hemorrhage
10/2020 - 01/2017
2
Inflammation (Inflammations)
10/2020 - 01/2016
2
Disseminated Intravascular Coagulation
10/2020 - 01/2008
2
Ischemic Stroke
03/2016 - 07/2015
2
Cardiovascular Diseases (Cardiovascular Disease)
09/2008 - 08/2003
2
Squamous Cell Carcinoma of Head and Neck
03/2008 - 09/2005
1
Infections
10/2020
1
Prostatic Neoplasms (Prostate Cancer)
01/2019
1
Polycystic Kidney Diseases (Polycystic Kidney Disease)
07/2016
1
Carcinogenesis
03/2016
1
Myocardial Infarction
03/2016
1
Pulmonary Embolism
03/2016
1
Skin Diseases (Skin Disease)
03/2015
1
Lymphatic Metastasis
03/2008
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2007
1
Colonic Neoplasms (Colon Cancer)
08/2004
1
Adenocarcinoma
08/2004
1
Noninfiltrating Intraductal Carcinoma (DCIS)
11/2003
Drug/Important Bio-Agent (IBA)
10
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2019 - 03/2004
10
Plasminogen Activators (Plasminogen Activator)
IBA
03/2011 - 06/2002
9
Plasminogen Activator Inhibitor 1
IBA
08/2011 - 11/2003
5
Serpins
IBA
01/2016 - 08/2003
4
Serine Proteases (Serine Protease)
IBA
03/2016 - 12/2012
4
Plasminogen
IBA
03/2016 - 05/2003
4
Peptide Hydrolases (Proteases)
FDA Link
03/2015 - 07/2007
4
Messenger RNA (mRNA)
IBA
06/2010 - 05/2003
3
Fibrinolysin
FDA Link
03/2016 - 10/2009
3
Antibodies
IBA
08/2011 - 11/2003
2
Tissue Plasminogen Activator (Alteplase)
FDA Link
03/2016 - 07/2015
2
Enzyme Precursors (Zymogens)
IBA
03/2016 - 02/2009
2
Peptide Library
IBA
10/2011 - 06/2008
2
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
10/2011 - 09/2011
2
Epitopes
IBA
08/2011 - 02/2009
2
Proteins (Proteins, Gene)
FDA Link
03/2008 - 09/2007
2
Biomarkers (Surrogate Marker)
IBA
09/2007 - 11/2003
1
Lipopolysaccharides
IBA
10/2020
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
10/2020
1
Dacarbazine (DIC)
FDA Link
Generic
10/2020
1
embelin
IBA
10/2020
1
Anticoagulants
IBA
10/2020
1
Peptides (Polypeptides)
IBA
01/2019
1
Cyclic Peptides
IBA
01/2019
1
trypsin-like serine protease
IBA
01/2017
1
Lysine (L-Lysine)
FDA Link
01/2017
1
HGF activator
IBA
07/2016
1
Matrix Metalloproteinase 14 (MT1-MMP)
IBA
03/2016
1
Collagen
IBA
03/2016
1
Immunoglobulin Fragments
IBA
03/2016
1
Fibrinolytic Agents (Antithrombotic Agents)
IBA
03/2016
1
Trypsin
IBA
03/2016
1
Fibrin
IBA
03/2016
1
LDL Lipoproteins (beta Lipoproteins)
IBA
07/2015
1
oxidized low density lipoprotein
IBA
07/2015
1
Elements
IBA
01/2013
1
matrigel
IBA
12/2012
1
Aprotinin (Trasylol)
FDA Link
09/2011
1
Monoclonal Antibodies
IBA
08/2011
1
hydrogen sulfite (bisulfite)
IBA
06/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2009
1
Protein C
IBA
01/2008
1
Factor VII (Proconvertin)
IBA
07/2007
1
RNA (Ribonucleic Acid)
IBA
07/2007
1
Plasminogen Inactivators
IBA
03/2004
1
Paraffin
IBA
11/2003
1
Formaldehyde (Formol)
FDA Link
11/2003
1
XR 5118
IBA
08/2003
1
Glycoproteins (Glycoprotein)
IBA
05/2003
1
Vitronectin
IBA
05/2003
1
Integrins
IBA
05/2003
Therapy/Procedure
4
Therapeutics
10/2007 - 06/2002